EdgarLookup

KESTRA MEDICAL TECHNOLOGIES, LTD. — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that KESTRA MEDICAL TECHNOLOGIES, LTD. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Revenue — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2026 Jan 31, 2026 $24.55M Mar 17, 2026
Q2 2025 Oct 31, 2025 $22.57M Dec 11, 2025
Q1 2025 Jul 31, 2025 $19.37M Sep 12, 2025
Q3 2026 Jan 31, 2025 $15.09M Mar 17, 2026
Q2 2025 Oct 31, 2024 $14.71M Dec 11, 2025
Q1 2025 Jul 31, 2024 $12.78M Sep 12, 2025

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2026 Jan 31, 2026 ($34.17M) Mar 17, 2026
Q2 2025 Oct 31, 2025 ($32.79M) Dec 11, 2025
Q1 2025 Jul 31, 2025 ($25.83M) Sep 12, 2025
Q3 2026 Jan 31, 2025 ($21.51M) Mar 17, 2026
Q2 2025 Oct 31, 2024 ($20.37M) Dec 11, 2025
Q1 2025 Jul 31, 2024 ($19.88M) Sep 12, 2025

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2026 Jan 31, 2026 ($34.77M) Mar 17, 2026
Q2 2025 Oct 31, 2025 ($31.76M) Dec 11, 2025
Q1 2025 Jul 31, 2025 ($28.88M) Sep 12, 2025
Q3 2026 Jan 31, 2025 ($20.60M) Mar 17, 2026
Q2 2025 Oct 31, 2024 ($19.13M) Dec 11, 2025
Q1 2025 Jul 31, 2024 ($18.43M) Sep 12, 2025